Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders.

Saved in:
Bibliographic Details
Title: Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders.
Authors: Strober, Bruce1 (AUTHOR), Armstrong, April2 (AUTHOR), Rubant, Simone3 (AUTHOR), Patel, Manish3 (AUTHOR), Wu, Tianshuang3 (AUTHOR), Photowala, Huzefa3 (AUTHOR), Crowley, Jeffrey4 (AUTHOR)
Source: Journal of Dermatological Treatment. Nov2022, Vol. 33 Issue 7, p2991-2996. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 160114005
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Strober%2C+Bruce%22">Strober, Bruce</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Armstrong%2C+April%22">Armstrong, April</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rubant%2C+Simone%22">Rubant, Simone</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+Manish%22">Patel, Manish</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Tianshuang%22">Wu, Tianshuang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Photowala%2C+Huzefa%22">Photowala, Huzefa</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crowley%2C+Jeffrey%22">Crowley, Jeffrey</searchLink><relatesTo>4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Dermatological+Treatment%22">Journal of Dermatological Treatment</searchLink>. Nov2022, Vol. 33 Issue 7, p2991-2996. 6p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160114005
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09546634.2022.2095328
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 2991
    Titles:
      – TitleFull: Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strober, Bruce
      – PersonEntity:
          Name:
            NameFull: Armstrong, April
      – PersonEntity:
          Name:
            NameFull: Rubant, Simone
      – PersonEntity:
          Name:
            NameFull: Patel, Manish
      – PersonEntity:
          Name:
            NameFull: Wu, Tianshuang
      – PersonEntity:
          Name:
            NameFull: Photowala, Huzefa
      – PersonEntity:
          Name:
            NameFull: Crowley, Jeffrey
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09546634
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of Dermatological Treatment
              Type: main
ResultId 1